Invention Grant
- Patent Title: Immunoglobulin constant region Fc receptor binding agents
-
Application No.: US16226964Application Date: 2018-12-20
-
Publication No.: US10941191B2Publication Date: 2021-03-09
- Inventor: Scott E. Strome , Dan H. Schulze , David S. Block , Henrik Olsen
- Applicant: University of Maryland, Baltimore , Gliknik Inc.
- Applicant Address: US MD Baltimore; US MD Baltimore
- Assignee: University of Maryland, Baltimore,Gliknik Inc.
- Current Assignee: University of Maryland, Baltimore,Gliknik Inc.
- Current Assignee Address: US MD Baltimore; US MD Baltimore
- Agency: Cooley LLP
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61P21/04 ; A61P19/02 ; C07K16/00 ; C07K16/06 ; C07K16/32 ; C07K16/28 ; G01N33/50 ; A61K39/00
Abstract:
IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are then screened in vitro to assess each replacement compound's efficiency at modulating immune function. Particular replacement compounds are selected for further in vivo validation and dosage/administration optimization. Finally, the replacement compounds are used to treat a wide range of diseases, including inflammatory and autoimmune diseases.
Public/Granted literature
- US20190218275A1 IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS Public/Granted day:2019-07-18
Information query
